A platform for phenotyping disease progression and associated longitudinal risk factors in large-scale EHRs, with application to incident diabetes complications in the UK Biobank
Related Posts
Jahr JS, Dang J, Tong A, Iskandar S, Patel A, Grogan T, Hopster K, Driessen B, Gunther RA. Decreases in hemoglobin and hematocrit may signal[...]
Narain K, Scannell C. Exploring Racial and Ethnic Differences in Utilization of Medications for Obesity Management in a Nationally Representative Survey. J Racial Ethn Health[...]
Overcoming Challenges in Small-Molecule Drug Bioavailability: A Review of Key Factors and Approaches
Wu K, Kwon SH, Zhou X, Fuller C, Wang X, Vadgama J, Wu Y. Overcoming Challenges in Small-Molecule Drug Bioavailability: A Review of Key Factors[...]